A revolutionary approach in the realm of ionic thermoelectric (i-TE) materials h...
In an increasingly complex landscape of mental health treatment, Fayzan Rab, a m...
As dogs age, their owner-assessed quality of life predictably declines, with hig...
A new international collaborative study from scientists at Scripps Research, the...
Scientists often grapple with the profound challenge of monitoring molecular cha...
LAWRENCE — A new book of natural history essays co-written by a University of Ka...
The plight of the Parma wallaby, a species struggling against the odds, has draw...
The U.S. Food and Drug Administration (FDA) has imposed restrictions on the impo...
Sanofi has announced a new step forward in its collaboration with SK bioscience,...
Novo Nordisk got a once-daily hemophilia injection cleared days before 2025. Nov...
Fifteen years ago, as concerns about the growing opioid crisis began to emerge, ...
Tricaprilin is under clinical development by Cerecin and currently in Phase II f...
Gene Therapy to Target GD2 for Oncology is under clinical development by Bristol...
Gene Therapy to Target GD2 for Oncology is under clinical development by Bristol...
Nelivaptan is under clinical development by HMNC and currently in Phase II for M...
Darigabat is under clinical development by Cerevel Therapeutics and currently in...
